Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sovak

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Investigative Radiology|March 1, 1973
Adhesive contrast material in the canine upper urinary tractM Sovak, L B Talner, H N Rushmer, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Iotrol, a new myelographic agent: 1. Radiography, CT, CSF clearance, and brain penetrationC W Kerber, M Sovak, R S Ranganathan, et al.
Spine|July 1, 1986
Brain changes on computed tomography following metrizamide myelography. Significance and therapeutic implicationsR S Centeno, M Sovak, D B Hackney, et al.
Journal of Medicinal Chemistry|December 1, 1976
Studies in the design of x-ray contrast agents. Synthesis, hydrophobicity, and solubility of some iodoresorcyl bis(beta-glucosides)F L Weitl, M Sovak, T M Williams, et al.
The Journal of Surgical Research|March 1, 1972
Portal vein blood flow determination in the unanesthetized human by umbilicoportal cannulationF A Reichle, M Sovak, R L Soulen, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysisM Sovak, R Ranganathan, C W Kerber, et al.
Headache|May 1, 1977
Vascular reactivity of migraineurs and non-migraineursM Sovak, A Fronek, R A Sternbach, et al.
Anti-Cancer Drugs|May 4, 2001
A new prodrug of paclitaxel: synthesis of ProtaxelA L Seligson, R C Terry, J C Bressi, et al.
Investigative Radiology|January 1, 1980
Direct myocardial effects of intracoronary administration of new contrast materials with lost osmolalityC B Higgins, M Sovak, W S Schmidt, et al.
Radiology|October 1, 1977
Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactionsE C Lasser, J Lang, M Sovak, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Investigative Radiology|March 1, 1973
Adhesive contrast material in the canine upper urinary tractM Sovak, L B Talner, H N Rushmer, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Iotrol, a new myelographic agent: 1. Radiography, CT, CSF clearance, and brain penetrationC W Kerber, M Sovak, R S Ranganathan, et al.
Spine|July 1, 1986
Brain changes on computed tomography following metrizamide myelography. Significance and therapeutic implicationsR S Centeno, M Sovak, D B Hackney, et al.
Journal of Medicinal Chemistry|December 1, 1976
Studies in the design of x-ray contrast agents. Synthesis, hydrophobicity, and solubility of some iodoresorcyl bis(beta-glucosides)F L Weitl, M Sovak, T M Williams, et al.
The Journal of Surgical Research|March 1, 1972
Portal vein blood flow determination in the unanesthetized human by umbilicoportal cannulationF A Reichle, M Sovak, R L Soulen, et al.
AJNR. American Journal of Neuroradiology|May 1, 1983
Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysisM Sovak, R Ranganathan, C W Kerber, et al.
Headache|May 1, 1977
Vascular reactivity of migraineurs and non-migraineursM Sovak, A Fronek, R A Sternbach, et al.
Anti-Cancer Drugs|May 4, 2001
A new prodrug of paclitaxel: synthesis of ProtaxelA L Seligson, R C Terry, J C Bressi, et al.
Investigative Radiology|January 1, 1980
Direct myocardial effects of intracoronary administration of new contrast materials with lost osmolalityC B Higgins, M Sovak, W S Schmidt, et al.
Radiology|October 1, 1977
Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactionsE C Lasser, J Lang, M Sovak, et al.
Pageof 7